Inspection Report Summary for Foothills Senior Care

Foothills Senior Care Facility, a 740‑type licensed home for up to six residents, has demonstrated consistent compliance with California licensing requirements over the past four annual inspections. In June 2021, May 2022, May 2023, and April 2024, the California Department of Social Services’ Community Care Licensing Division conducted unannounced, infection‑control‑focused visits. In each instance the Licensing Program Analyst toured all resident rooms, common areas, bathrooms, the kitchen, and outdoor spaces, found no health, safety, or personal‑rights violations, and concluded the facility was in “substantial compliance.” The analyst also reviewed staff and resident files, medication records, and proof of liability insurance, all of which met the agency’s standards. In 2021, the analyst requested supplemental documents—designation of administrative responsibility, personnel report, and proof of liability insurance—to be submitted by the close of business on 6 18 2021, but no deficiencies were cited.

The recurring pattern of thorough documentation and proactive staff training is evident across the inspections. Each report notes that all residents received adequate nutrition, linens, and first‑aid supplies; emergency exits were clear and unlocked; medication storage was secured; and water temperatures were within acceptable limits. The facility’s staff hold current criminal record clearances and first‑aid certificates, and the facility maintains up‑to‑date liability coverage. These findings reinforce the facility’s ongoing commitment to resident safety and regulatory compliance.

A shift occurred in the April 2025 case‑management visit, which followed a March 2025 incident report (LIC624) concerning medication management. During the review, the analyst identified a deficiency under Title 22, Division 6, Chapter 8, related to improper medication handling. The deficiency is classified as Type A, indicating an immediate risk to resident health, safety, or personal rights if uncorrected. The report includes a prescribed plan of correction, and the facility is required to demonstrate compliance within a specified timeframe. This isolated deficiency suggests a lapse in medication oversight that, while addressed promptly, underscores the importance of continual vigilance in clinical protocols.